Lattuada E - Search Results

1

Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir.

Lanzafame M, Nicole S, Rizzardo S, Piacentini D, Chiesi S, Lattuada E, Diani E, Carelli M, Vento S, Gibellini D. Lanzafame M, et al. Among authors: lattuada e. New Microbiol. 2018 Oct;41(4):262-267. Epub 2018 Oct 12. New Microbiol. 2018. PMID: 30311623 Free article. Clinical Trial.

2

Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report.

Lanzafame M, Trevenzoli M, Lattuada E, Faggian F, Vento S, Concia E. Lanzafame M, et al. Among authors: lattuada e. Infez Med. 2003 Mar;11(1):40-1. Infez Med. 2003. PMID: 12719670 Free article.

3

Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection.

Lattuada E, Puppini G, Faggian F, Lanzafame M, Concia E. Lattuada E, et al. Lancet Infect Dis. 2004 Mar;4(3):170. doi: 10.1016/S1473-3099(04)00941-7. Lancet Infect Dis. 2004. PMID: 14998503 No abstract available.

4

Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report.

Faggian F, Lattuada E, Lanzafame M, Trevenzoli M, Cattelan AM, Concia E. Faggian F, et al. Among authors: lattuada e. Infez Med. 2003 Jun;11(2):102-4. Infez Med. 2003. PMID: 15020855 Free article.

5

Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era.

Faggian F, Lanzafame M, Lattuada E, Brugnaro P, Carretta G, Cadrobbi P, Concia E. Faggian F, et al. Among authors: lattuada e. South Med J. 2004 Apr;97(4):398-400. doi: 10.1097/01.SMJ.0000084290.81423.21. South Med J. 2004. PMID: 15108837

6

[No improvement of lipodystrophy syndrome in an HIV-infected patient].

Lanzafame M, Faggian F, Lattuada E, Antolini D, Concia E. Lanzafame M, et al. Among authors: lattuada e. Recenti Prog Med. 2004 Jun;95(6):312-3. Recenti Prog Med. 2004. PMID: 15248414 Italian.

7

Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restoration.

Lanzafame M, Faggian F, Lattuada E, Antolini D, Vento S. Lanzafame M, et al. Among authors: lattuada e. J Infect Dis. 2005 Mar 15;191(6):1027. doi: 10.1086/428099. J Infect Dis. 2005. PMID: 15717283 No abstract available.

8

Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature.

Lattuada E, Zorzi A, Lanzafame M, Antolini D, Fontana R, Vento S, Concia E. Lattuada E, et al. J Infect. 2005 Aug;51(2):E71-2. doi: 10.1016/j.jinf.2004.08.026. J Infect. 2005. PMID: 16038756 Review.

9

Tenofovir-associated kidney diseases and interactions between tenofovir and other antiretrovirals.

Lanzafame M, Lattuada E, Rapagna F, Gottardi M, Vento S. Lanzafame M, et al. Among authors: lattuada e. Clin Infect Dis. 2006 Jun 1;42(11):1656-7; author reply 1658. doi: 10.1086/504089. Clin Infect Dis. 2006. PMID: 16652329 No abstract available.

10

Selective drug taking during combination antiretroviral therapy.

Lanzafame M, Melotti R, Lattuada E, Boccafoglio F, Concia E, Verlato G, Vento S. Lanzafame M, et al. Among authors: lattuada e. J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):490-1. doi: 10.1097/QAI.0b013e318031d033. J Acquir Immune Defic Syndr. 2007. PMID: 17353720 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters